Teradyne (TER) Tops Q1 EPS by 6c, Offers Guidance

Teradyne (NASDAQ: TER) reported Q1 EPS of $1.11, $0.06 better than the analyst estimate of $1.05. Revenue for the quarter came in at $782 million versus the consensus estimate of $760.42 million.

GUIDANCE:

Teradyne sees Q2 2021 EPS of $1.62-$1.83, versus the consensus of $1.32. Teradyne sees Q2 2021 revenue of $1.01-1.09 billion, versus the consensus of $877 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance